News of Note—GlaxoSmithKline, VLP Therapeutics and more


Here is some other vaccine news of note for the week:

> GlaxoSmithKline's vaccine sales grew 16% last year to £5.9 billion ($7.64 billion). Shingrix sales hit £784 million ($1 billion) in its first full year on the market. Release

> Gaithersburg, Maryland-based VLP Therapeutics said it plans to kick off an initial clinical study of its malaria vaccine candidate. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.

> Officials in Kentucky are looking into vaccine-associated infections in Kentucky, Ohio and Indiana due to possible improper handling and storage by a service provider. Release (PDF)